07:41 AM EDT, 09/05/2024 (MT Newswires) -- Merck ( MRK ) said Thursday that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance for Welireg on Aug. 30.

The alliance negotiates on behalf of Canadian provinces and federal programs, bringing the drug, also known as belzutifan, closer to public reimbursement.

Price: 116.03, Change: +0.23, Percent Change: +0.20